Interaction of multitargeted tyrosine kinase inhibitors with human nucleoside transporters

被引：0
|
作者：
Damaraju, Vijaya L. [1 ]
Kuzma, Michelle [1 ]
Mowles, Delores [1 ]
Cass, Carol E. [2 ]
Sawyer, Michael B. [1 ]
机构：
[1] Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada
[2] Univ Alberta, Edmonton, AB, Canada
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-797
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
797
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Oral dysesthesia in cancer patients (Pts) treated with multitargeted tyrosine kinase inhibitors (MT-TKI).
    Yuan, Anna D.
    Kurtz, Sharyn L.
    Barysauskas, Constance
    Pilotte, Amy P.
    Wagner, Andrew J.
    Treister, Nathaniel S.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [32] MEDI 360-Azaindazole ureas as potent VEGFR/PDGFR multitargeted receptor tyrosine kinase inhibitors
    Dai, Yujia
    Hartandi, Kresna
    Albert, Daniel H.
    Bouska, Jennifer J.
    Bokofzer, Gait T.
    Donawho, Cherrie K.
    Glaser, Keith B.
    Guo, Jun
    Li, Junling
    Marcotte, Patrick A.
    Olson, Amanda M.
    Osterling, Donald J.
    Pease, Lori J.
    Soni, Niru B.
    Stewart, Kent D.
    Tapang, Paul
    Reuter, David R.
    Davidsen, Steven K.
    Michaelides, Michael R.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 234
  • [33] 7-Aminopyrazolo[1,5-a]pyrimidines as potent multitargeted receptor tyrosine kinase inhibitors
    Frey, Robin R.
    Curtin, Michael L.
    Albert, Daniel H.
    Glaser, Keith B.
    Pease, Lori J.
    Soni, Niru B.
    Bouska, Jennifer J.
    Reuter, David
    Stewart, Kent D.
    Marcotte, Patrick
    Bukofzer, Gail
    Li, Junling
    Davidsen, Steven K.
    Michaelides, Michael R.
    JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (13) : 3777 - 3787
  • [34] Targeting Neovasculature with Multitargeted Antiangiogenesis Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer
    Vasileios S. Skouras
    Charis Maragkos
    Dimitra Grapsa
    Konstantinos N. Syrigos
    BioDrugs, 2016, 30 : 421 - 439
  • [35] Effects of 4 multitargeted receptor tyrosine kinase inhibitors on regional hemodynamics in conscious, freely moving rats
    Carter, Joanne J.
    Fretwell, Laurice V.
    Woolard, Jeanette
    FASEB JOURNAL, 2017, 31 (03): : 1193 - 1203
  • [36] Targeting Neovasculature with Multitargeted Antiangiogenesis Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer
    Skouras, Vasileios S.
    Maragkos, Charis
    Grapsa, Dimitra
    Syrigos, Konstantinos N.
    BIODRUGS, 2016, 30 (05) : 421 - 439
  • [37] RGD mutants and inhibitors for human nucleoside diphosphate kinase A.
    Yeh, AYC
    Yeh, HW
    FASEB JOURNAL, 1997, 11 (03): : 3130 - 3130
  • [38] Cardiovascular toxicity associated with the multitargeted tyrosine kinase inhibitor anlotinib
    Zhao, Shu
    Wang, Peng
    Yin, Fan
    Wu, Junjie
    Wang, Yuying
    Li, Peng
    Zhang, Yong
    Yang, Jing
    Guo, Xueguang
    Zhang, Dong
    Song, Peng
    TUMORI JOURNAL, 2023, 109 (02): : 186 - 196
  • [39] NUCLEOSIDE INHIBITORS OF RHODOPSIN KINASE
    PALCZEWSKI, K
    KAHN, N
    HARGRAVE, PA
    BIOCHEMISTRY, 1990, 29 (26) : 6276 - 6282
  • [40] Sunitinib malate -: Oncolytic drug multitargeted tyrosine kinase inhibitor
    McIntyre, JA
    Castañer, J
    DRUGS OF THE FUTURE, 2005, 30 (08) : 785 - 792
12345